United States Biotechnology & Medical Research

TFF Pharmaceuticals Inc (TFFP)

Track

Track

Ticker: TFFP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for TFF Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
CARLSON CAPITAL L P Large shareholder
Transaction date
Sale
Price
393.70
Quantity 9,846 +17.9%
Value US$1,075,266
2.0
CARLSON CAPITAL L P Large shareholder
Transaction date
Sale
Price
43.21
Quantity 54,573 +47.1%
Value US$4,908,981
2.5
MILLS ROBERT S Non-Executive Director
Transaction date
Purchase
Price
281.40
Quantity 82,022 +18.9%
Value US$2,079,845
0.5
Mikhak Zamaneh Chief Medical Officer Officer
Transaction date
Purchase
Price
0.25
Quantity 120,000 +800.0%
Value US$30,000
3.4
ROCAMBOLI STEPHEN Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 20,000 +125.0%
Value US$5,000
2.9
COLEMAN KIRK ALLEN Chief Financial Officer Officer
Transaction date
Purchase
Price
0.25
Quantity 20,000 +127.6%
Value US$5,000
1.9
Weisman Harlan F President and CEO Executive Director
Transaction date
Purchase
Price
0.25
Quantity 600,000 +279.6%
Value US$150,000
Roberts Brandi Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 20,000 +inf%
Value US$5,000
1.9
Weisman Harlan F President and CEO Executive Director
Transaction date
Purchase
Price
0.88
Quantity 150,000 +232.1%
Value US$131,835
3.4
ROCAMBOLI STEPHEN Non-Executive Director
Transaction date
Purchase
Price
0.80
Quantity 13,000 +433.3%
Value US$10,432
0.5
Mikhak Zamaneh Chief Medical Officer Officer
Transaction date
Purchase
Price
0.82
Quantity 15,000 +inf%
Value US$12,300
2.9
COLEMAN KIRK ALLEN Chief Financial Officer Officer
Transaction date
Purchase
Price
0.79
Quantity 12,000 +326.5%
Value US$9,457
1.9
Weisman Harlan F President and CEO Executive Director
Transaction date
Purchase
Price
1.06
Quantity 50,000 +342.1%
Value US$53,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 43,470 +43.5%
Value US$49,990
1.9
Weisman Harlan F Non-Executive Director
Transaction date
Purchase
Price
5.50
Quantity 4,615 +46.2%
Value US$25,382
1.9
Weisman Harlan F Non-Executive Director
Transaction date
Purchase
Price
5.12
Quantity 2,500 +33.3%
Value US$12,800
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
5.08
Quantity 24,600 +28.9%
Value US$124,968
2.9
COLEMAN KIRK ALLEN Chief Financial Officer Officer
Transaction date
Purchase
Price
4.83
Quantity 425 +13.1%
Value US$2,053
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Purchase
Price
4.78
Quantity 16,000 +80.0%
Value US$76,480
3.4
ROCAMBOLI STEPHEN Non-Executive Director
Transaction date
Purchase
Price
4.54
Quantity 3,000 +19.1%
Value US$13,620
1.9
Weisman Harlan F Non-Executive Director
Transaction date
Purchase
Price
4.74
Quantity 2,500 +50.0%
Value US$11,850
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
4.86
Quantity 85,000 +inf%
Value US$413,100
2.9
COLEMAN KIRK ALLEN Chief Financial Officer Officer
Transaction date
Purchase
Price
4.40
Quantity 1,250 +62.5%
Value US$5,500
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
6.89
Quantity 42,000 +8.4%
Value US$289,380
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
6.43
Quantity 500,000 +inf%
Value US$3,215,000
2.2
Fairbairn Malcolm Non-Executive Director
Transaction date
Purchase
Price
8.95
Quantity 10,000 +inf%
Value US$89,500
3.0
THURMAN RANDY H Non-Executive Director
Transaction date
Purchase
Price
9.40
Quantity 1,050 +inf%
Value US$9,870
3.2
Lung Therapeutics, Inc. Large shareholder
Transaction date
Sale
Price
14.00
Quantity 715,000 -24.2%
Value US$10,010,000
3.4
ROCAMBOLI STEPHEN Non-Executive Director
Transaction date
Sale
Price
16.85
Quantity 20,006 -56.0%
Value US$337,101
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Planned sale
Price
17.04
Quantity 50,000 -83.3%
Value US$852,000
2.9
COLEMAN KIRK ALLEN CFO, Secretary and Treasurer Officer
Transaction date
Planned sale
Price
17.05
Quantity 5,000 -83.3%
Value US$85,250
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Planned sale
Price
16.82
Quantity 40,000 -80.0%
Value US$672,800
2.9
COLEMAN KIRK ALLEN CFO, Secretary and Treasurer Officer
Transaction date
Planned sale
Price
16.82
Quantity 5,000 -83.3%
Value US$84,100
2.5
MILLS ROBERT S Non-Executive Director
Transaction date
Planned sale
Price
20.16
Quantity 700 -4.2%
Value US$14,112
2.5
MILLS ROBERT S Non-Executive Director
Transaction date
Planned sale
Price
20.20
Quantity 12,600 -44.1%
Value US$254,520
2.5
MILLS ROBERT S Non-Executive Director
Transaction date
Planned sale
Price
19.56
Quantity 55,100 -77.5%
Value US$1,077,756
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 40,000 -80.0%
Value US$700,400
2.9
COLEMAN KIRK ALLEN CFO, Secretary and Treasurer Officer
Transaction date
Planned sale
Price
17.50
Quantity 5,000 -83.3%
Value US$87,500
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Planned sale
Price
15.33
Quantity 30,000 -75.0%
Value US$459,900
2.9
COLEMAN KIRK ALLEN CFO, Secretary and Treasurer Officer
Transaction date
Planned sale
Price
15.24
Quantity 10,000 -90.9%
Value US$152,400
2.5
MILLS ROBERT S Non-Executive Director
Transaction date
Sale
Price
14.58
Quantity 22,794 -58.8%
Value US$332,337
3.4
WINDSOR JAMES BRIAN Chief Science Officer Executive Director
Transaction date
Sale
Price
15.80
Quantity 25,000 -83.3%
Value US$395,000
3.2
Lung Therapeutics, Inc. Large shareholder
Transaction date
Sale
Price
13.86
Quantity 250,000 -7.8%
Value US$3,465,000
3.2
Lung Therapeutics, Inc. Large shareholder
Transaction date
Sale
Price
13.86
Quantity 300,000 -8.6%
Value US$4,158,000
3.2
Lung Therapeutics, Inc. Large shareholder
Transaction date
Sale
Price
13.85
Quantity 500,000 -12.5%
Value US$6,925,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
15.13
Quantity 5,000 +5.3%
Value US$75,656
3.0
THURMAN RANDY H Non-Executive Director
Transaction date
Sale
Price
17.17
Quantity 5,000 -100.0%
Value US$85,865
2.2
Fairbairn Malcolm Non-Executive Director
Transaction date
Sale
Price
15.97
Quantity 11,669 -100.0%
Value US$186,307
3.4
ROCAMBOLI STEPHEN Non-Executive Director
Transaction date
Sale
Price
15.76
Quantity 15,722 -100.0%
Value US$247,732
3.0
THURMAN RANDY H Non-Executive Director
Transaction date
Sale
Price
15.91
Quantity 34,504 -87.3%
Value US$548,890
2.2
Fairbairn Malcolm Non-Executive Director
Transaction date
Sale
Price
15.93
Quantity 63,331 -84.4%
Value US$1,008,926
3.4
ROCAMBOLI STEPHEN Non-Executive Director
Transaction date
Sale
Price
15.14
Quantity 21,278 -100.0%
Value US$322,106
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Sale
Price
15.00
Quantity 108,830 -91.6%
Value US$1,631,906
2.9
COLEMAN KIRK ALLEN CFO, Secretary, and Treasurer Officer
Transaction date
Sale
Price
15.12
Quantity 15,000 -93.8%
Value US$226,755
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Sale
Price
17.00
Quantity 3,000 -30.0%
Value US$51,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
5.08
Quantity 20,000 +26.7%
Value US$101,600
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
4.72
Quantity 5,581 +8.0%
Value US$26,342
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
4.24
Quantity 6,252 +9.9%
Value US$26,508
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
3.97
Quantity 16,748 +36.1%
Value US$66,490
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 500 +1.1%
Value US$1,875
2.9
COLEMAN KIRK ALLEN CFO, Secretary, and Treasurer
Transaction date
Purchase
Price
5.00
Quantity 1,000 +inf%
Value US$5,000
2.5
MILLS ROBERT S
Transaction date
Purchase
Price
5.00
Quantity 5,000 +inf%
Value US$25,000
3.0
THURMAN RANDY H
Transaction date
Purchase
Price
5.00
Quantity 5,000 +inf%
Value US$25,000
3.1
Mattes Glenn R. President and CEO Executive Director
Transaction date
Purchase
Price
5.00
Quantity 10,000 +inf%
Value US$50,000
1.9
Weisman Harlan F
Transaction date
Purchase
Price
5.00
Quantity 5,000 +inf%
Value US$25,000
3.4
WINDSOR JAMES BRIAN Chief Science Officer Executive Director
Transaction date
Purchase
Price
5.00
Quantity 5,000 +inf%
Value US$25,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-17 2023-08-16 S Sale
2.0
CARLSON CAPITAL L P
Large shareholder
9,846 +17.9%
393.70
US$1,075,266 		9,846 +17.9% 393.70 US$1,075,266
2023-08-17 2023-08-15 S Sale
2.0
CARLSON CAPITAL L P
Large shareholder
54,573 +47.1%
43.21
US$4,908,981 		54,573 +47.1% 43.21 US$4,908,981
2023-08-15 2023-08-15 B Purchase
2.5
MILLS ROBERT S
Non-Executive Director
82,022 +18.9%
281.40
US$2,079,845 		82,022 +18.9% 281.40 US$2,079,845
2023-08-15 2023-08-15 B Purchase
0.5
Mikhak Zamaneh

Chief Medical Officer

Officer
120,000 +800.0%
0.25
US$30,000 		120,000 +800.0% 0.25 US$30,000
2023-08-15 2023-08-15 B Purchase
3.4
ROCAMBOLI STEPHEN
Non-Executive Director
20,000 +125.0%
0.25
US$5,000 		20,000 +125.0% 0.25 US$5,000
2023-08-15 2023-08-15 B Purchase
2.9
COLEMAN KIRK ALLEN

Chief Financial Officer

Officer
20,000 +127.6%
0.25
US$5,000 		20,000 +127.6% 0.25 US$5,000
2023-08-15 2023-08-15 B Purchase
1.9
Weisman Harlan F

President and CEO

Executive Director
600,000 +279.6%
0.25
US$150,000 		600,000 +279.6% 0.25 US$150,000
2023-08-15 2023-08-15 B Purchase
Roberts Brandi
Non-Executive Director
20,000 +inf%
0.25
US$5,000 		20,000 +inf% 0.25 US$5,000
2023-03-13 2023-03-10 B Purchase
1.9
Weisman Harlan F

President and CEO

Executive Director
150,000 +232.1%
0.88
US$131,835 		150,000 +232.1% 0.88 US$131,835
2023-03-13 2023-03-10 B Purchase
3.4
ROCAMBOLI STEPHEN
Non-Executive Director
13,000 +433.3%
0.80
US$10,432 		13,000 +433.3% 0.80 US$10,432
2023-03-13 2023-03-10 B Purchase
0.5
Mikhak Zamaneh

Chief Medical Officer

Officer
15,000 +inf%
0.82
US$12,300 		15,000 +inf% 0.82 US$12,300
2023-03-13 2023-03-10 B Purchase
2.9
COLEMAN KIRK ALLEN

Chief Financial Officer

Officer
12,000 +326.5%
0.79
US$9,457 		12,000 +326.5% 0.79 US$9,457
2022-12-19 2022-12-15 B Purchase
1.9
Weisman Harlan F

President and CEO

Executive Director
50,000 +342.1%
1.06
US$53,000 		50,000 +342.1% 1.06 US$53,000
2022-11-23 2022-11-22 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
43,470 +43.5%
1.15
US$49,990 		43,470 +43.5% 1.15 US$49,990
2022-05-20 2022-05-20 B Purchase
1.9
Weisman Harlan F
Non-Executive Director
4,615 +46.2%
5.50
US$25,382 		4,615 +46.2% 5.50 US$25,382
2022-05-20 2022-05-18 B Purchase
1.9
Weisman Harlan F
Non-Executive Director
2,500 +33.3%
5.12
US$12,800 		2,500 +33.3% 5.12 US$12,800
2022-05-17 2022-05-17 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
24,600 +28.9%
5.08
US$124,968 		24,600 +28.9% 5.08 US$124,968
2022-05-17 2022-05-17 B Purchase
2.9
COLEMAN KIRK ALLEN

Chief Financial Officer

Officer
425 +13.1%
4.83
US$2,053 		425 +13.1% 4.83 US$2,053
2022-05-17 2022-05-16 B Purchase
3.1
Mattes Glenn R.

President and CEO

Executive Director
16,000 +80.0%
4.78
US$76,480 		16,000 +80.0% 4.78 US$76,480
2022-05-17 2022-05-16 B Purchase
3.4
ROCAMBOLI STEPHEN
Non-Executive Director
3,000 +19.1%
4.54
US$13,620 		3,000 +19.1% 4.54 US$13,620
2022-05-17 2022-05-16 B Purchase
1.9
Weisman Harlan F
Non-Executive Director
2,500 +50.0%
4.74
US$11,850 		2,500 +50.0% 4.74 US$11,850
2022-05-17 2022-05-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
85,000 +inf%
4.86
US$413,100 		85,000 +inf% 4.86 US$413,100
2022-05-17 2022-05-16 B Purchase
2.9
COLEMAN KIRK ALLEN

Chief Financial Officer

Officer
1,250 +62.5%
4.40
US$5,500 		1,250 +62.5% 4.40 US$5,500
2022-04-04 2022-04-04 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
42,000 +8.4%
6.89
US$289,380 		42,000 +8.4% 6.89 US$289,380
2022-04-04 2022-04-04 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
500,000 +inf%
6.43
US$3,215,000 		500,000 +inf% 6.43 US$3,215,000
2021-05-19 2021-05-19 B Purchase
2.2
Fairbairn Malcolm
Non-Executive Director
10,000 +inf%
8.95
US$89,500 		10,000 +inf% 8.95 US$89,500
2021-05-19 2021-05-18 B Purchase
3.0
THURMAN RANDY H
Non-Executive Director
1,050 +inf%
9.40
US$9,870 		1,050 +inf% 9.40 US$9,870
2021-03-30 2021-03-26 S Sale
3.2
Lung Therapeutics, Inc.
Large shareholder
715,000 -24.2%
14.00
US$10,010,000 		715,000 -24.2% 14.00 US$10,010,000
2021-03-17 2021-03-15 S Sale
3.4
ROCAMBOLI STEPHEN
Non-Executive Director
20,006 -56.0%
16.85
US$337,101 		20,006 -56.0% 16.85 US$337,101
2021-03-17 2021-03-15 PlS Planned sale
3.1
Mattes Glenn R.

President and CEO

Executive Director
50,000 -83.3%
17.04
US$852,000 		50,000 -83.3% 17.04 US$852,000
2021-03-17 2021-03-15 PlS Planned sale
2.9
COLEMAN KIRK ALLEN

CFO, Secretary and Treasurer

Officer
5,000 -83.3%
17.05
US$85,250 		5,000 -83.3% 17.05 US$85,250
2021-02-18 2021-02-16 PlS Planned sale
3.1
Mattes Glenn R.

President and CEO

Executive Director
40,000 -80.0%
16.82
US$672,800 		40,000 -80.0% 16.82 US$672,800
2021-02-18 2021-02-16 PlS Planned sale
2.9
COLEMAN KIRK ALLEN

CFO, Secretary and Treasurer

Officer
5,000 -83.3%
16.82
US$84,100 		5,000 -83.3% 16.82 US$84,100
2021-02-12 2021-02-10 PlS Planned sale
2.5
MILLS ROBERT S
Non-Executive Director
700 -4.2%
20.16
US$14,112 		700 -4.2% 20.16 US$14,112
2021-01-20 2021-01-20 PlS Planned sale
2.5
MILLS ROBERT S
Non-Executive Director
12,600 -44.1%
20.20
US$254,520 		12,600 -44.1% 20.20 US$254,520
2021-01-20 2021-01-19 PlS Planned sale
2.5
MILLS ROBERT S
Non-Executive Director
55,100 -77.5%
19.56
US$1,077,756 		55,100 -77.5% 19.56 US$1,077,756
2021-01-20 2021-01-15 PlS Planned sale
3.1
Mattes Glenn R.

President and CEO

Executive Director
40,000 -80.0%
17.51
US$700,400 		40,000 -80.0% 17.51 US$700,400
2021-01-20 2021-01-15 PlS Planned sale
2.9
COLEMAN KIRK ALLEN

CFO, Secretary and Treasurer

Officer
5,000 -83.3%
17.50
US$87,500 		5,000 -83.3% 17.50 US$87,500
2020-12-29 2020-12-23 PlS Planned sale
3.1
Mattes Glenn R.

President and CEO

Executive Director
30,000 -75.0%
15.33
US$459,900 		30,000 -75.0% 15.33 US$459,900
2020-12-29 2020-12-23 PlS Planned sale
2.9
COLEMAN KIRK ALLEN

CFO, Secretary and Treasurer

Officer
10,000 -90.9%
15.24
US$152,400 		10,000 -90.9% 15.24 US$152,400
2020-12-15 2020-12-11 S Sale
2.5
MILLS ROBERT S
Non-Executive Director
22,794 -58.8%
14.58
US$332,337 		22,794 -58.8% 14.58 US$332,337
2020-12-09 2020-12-07 S Sale
3.4
WINDSOR JAMES BRIAN

Chief Science Officer

Executive Director
25,000 -83.3%
15.80
US$395,000 		25,000 -83.3% 15.80 US$395,000
2020-12-08 2020-12-04 S Sale
3.2
Lung Therapeutics, Inc.
Large shareholder
250,000 -7.8%
13.86
US$3,465,000 		250,000 -7.8% 13.86 US$3,465,000
2020-12-08 2020-12-04 S Sale
3.2
Lung Therapeutics, Inc.
Large shareholder
300,000 -8.6%
13.86
US$4,158,000 		300,000 -8.6% 13.86 US$4,158,000
2020-12-08 2020-12-04 S Sale
3.2
Lung Therapeutics, Inc.
Large shareholder
500,000 -12.5%
13.85
US$6,925,000 		500,000 -12.5% 13.85 US$6,925,000
2020-11-24 2020-11-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
5,000 +5.3%
15.13
US$75,656 		5,000 +5.3% 15.13 US$75,656
2020-11-13 2020-11-13 S Sale
3.0
THURMAN RANDY H
Non-Executive Director
5,000 -100.0%
17.17
US$85,865 		5,000 -100.0% 17.17 US$85,865
2020-11-13 2020-11-12 S Sale
2.2
Fairbairn Malcolm
Non-Executive Director
11,669 -100.0%
15.97
US$186,307 		11,669 -100.0% 15.97 US$186,307
2020-11-13 2020-11-11 S Sale
3.4
ROCAMBOLI STEPHEN
Non-Executive Director
15,722 -100.0%
15.76
US$247,732 		15,722 -100.0% 15.76 US$247,732
2020-11-13 2020-11-11 S Sale
3.0
THURMAN RANDY H
Non-Executive Director
34,504 -87.3%
15.91
US$548,890 		34,504 -87.3% 15.91 US$548,890
2020-11-13 2020-11-11 S Sale
2.2
Fairbairn Malcolm
Non-Executive Director
63,331 -84.4%
15.93
US$1,008,926 		63,331 -84.4% 15.93 US$1,008,926
2020-11-13 2020-11-10 S Sale
3.4
ROCAMBOLI STEPHEN
Non-Executive Director
21,278 -100.0%
15.14
US$322,106 		21,278 -100.0% 15.14 US$322,106
2020-11-13 2020-11-10 S Sale
3.1
Mattes Glenn R.

President and CEO

Executive Director
108,830 -91.6%
15.00
US$1,631,906 		108,830 -91.6% 15.00 US$1,631,906
2020-11-13 2020-11-10 S Sale
2.9
COLEMAN KIRK ALLEN

CFO, Secretary, and Treasurer

Officer
15,000 -93.8%
15.12
US$226,755 		15,000 -93.8% 15.12 US$226,755
2021-01-20 2020-09-25 S Sale
3.1
Mattes Glenn R.

President and CEO

Executive Director
3,000 -30.0%
17.00
US$51,000 		3,000 -30.0% 17.00 US$51,000
2020-05-26 2020-05-26 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
20,000 +26.7%
5.08
US$101,600 		20,000 +26.7% 5.08 US$101,600
2020-04-17 2020-04-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
5,581 +8.0%
4.72
US$26,342 		5,581 +8.0% 4.72 US$26,342
2020-04-06 2020-04-06 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
6,252 +9.9%
4.24
US$26,508 		6,252 +9.9% 4.24 US$26,508
2020-04-06 2020-04-03 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
16,748 +36.1%
3.97
US$66,490 		16,748 +36.1% 3.97 US$66,490
2020-04-06 2020-04-02 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
500 +1.1%
3.75
US$1,875 		500 +1.1% 3.75 US$1,875
2019-10-29 2019-10-25 B Purchase
2.9
COLEMAN KIRK ALLEN

CFO, Secretary, and Treasurer
1,000 +inf%
5.00
US$5,000 		1,000 +inf% 5.00 US$5,000
2019-10-29 2019-10-25 B Purchase
2.5
MILLS ROBERT S
5,000 +inf%
5.00
US$25,000 		5,000 +inf% 5.00 US$25,000
2019-10-29 2019-10-25 B Purchase
3.0
THURMAN RANDY H
5,000 +inf%
5.00
US$25,000 		5,000 +inf% 5.00 US$25,000
2019-10-29 2019-10-25 B Purchase
3.1
Mattes Glenn R.

President and CEO

Executive Director
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2019-10-29 2019-10-25 B Purchase
1.9
Weisman Harlan F
5,000 +inf%
5.00
US$25,000 		5,000 +inf% 5.00 US$25,000
2019-10-29 2019-10-25 B Purchase
3.4
WINDSOR JAMES BRIAN

Chief Science Officer

Executive Director
5,000 +inf%
5.00
US$25,000 		5,000 +inf% 5.00 US$25,000
2019-10-29 2019-10-25 B Purchase
2.7
Fletcher Aaron G.L.
2,000 +inf%
5.00
US$10,000 		2,000 +inf% 5.00 US$10,000
Explore more

More insider trading research around TFF Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America